Penetrium Bioscience Inc. (KOSDAQ:187660)

Penetrium Bioscience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	5,779	3,373	3,097	5,270	8,565
Short-Term Investments	64.64	15,601	24,000	25,500	6,135
Trading Asset Securities	-	-	7,973	-	-
Cash & Short-Term Investments	5,843	18,974	35,070	30,770	14,700
Cash Growth	-69.20%	-45.90%	13.97%	109.32%	56.33%
Accounts Receivable	1,339	1,401	677.64	177.63	211.7
Other Receivables	57.03	403.43	415.26	152.83	38.47
Receivables	1,396	1,877	1,665	330.47	250.17
Inventory	-	1,163	402.48	203.51	46.25
Prepaid Expenses	345.9	90.27	169.06	127.92	53.32
Other Current Assets	3,733	3,452	3,283	4,018	3,840
Total Current Assets	11,319	25,555	40,589	35,450	18,889
Property, Plant & Equipment	1,728	2,849	2,792	1,422	472.09
Long-Term Investments	2,041	1,846	1,176	866.39	772.83
Other Intangible Assets	235.56	1,082	973.4	82.5	73.25
Long-Term Deferred Tax Assets	165.32	32.29	51.71	80.92	130.88
Other Long-Term Assets	13,039	12,849	709.26	463.04	397.53
Total Assets	28,527	44,214	46,292	38,365	20,736

Liabilities

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Accounts Payable	-	3.08	59.4	-	-
Accrued Expenses	186.26	224.2	351.9	318.36	371.29
Short-Term Debt	8,243	-	-	-	-
Current Portion of Leases	595.89	422.99	390.43	325.26	324.44
Current Income Taxes Payable	-	-	-	107.26	757.12
Other Current Liabilities	11,519	7,719	7,206	3,434	4,188
Total Current Liabilities	20,545	8,370	8,008	4,185	5,641
Long-Term Leases	448.91	267.38	250.88	9.83	19.57
Long-Term Unearned Revenue	32.28	46.91	-	-	-
Pension & Post-Retirement Benefits	-	-	-	280.61	366.66
Other Long-Term Liabilities	872.37	1,476	1,125	126.74	33.44
Total Liabilities	21,898	10,160	9,384	4,602	6,060

Shareholders' Equity

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Common Stock	4,299	2,184	2,184	2,184	1,720
Additional Paid-In Capital	18,309	20,419	20,419	21,177	4,576
Retained Earnings	-12,065	8,276	11,462	11,185	9,059
Treasury Stock	-2,826	-2,737	-2,737	-	-
Comprehensive Income & Other	-894.64	-990.77	-986.24	-958.13	-1,014
Total Common Equity	6,822	27,151	30,341	33,587	14,341
Minority Interest	-193.51	-23.21	369.19	-130.53	72.11
Shareholders' Equity	6,629	34,055	36,909	33,762	14,676
Total Liabilities & Equity	28,527	44,214	46,292	38,365	20,736

Additional Metrics

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Debt	9,288	690.36	641.31	335.09	344.01
Net Cash (Debt)	-3,445	18,283	34,429	30,435	14,356
Net Cash Growth	-	-46.89%	13.12%	112.01%	58.13%
Net Cash Per Share	-81.43	432.17	762.19	763.49	417.29
Filing Date Shares Outstanding	42.29	42.31	42.31	43.67	34.4
Total Common Shares Outstanding	42.29	42.31	42.31	43.67	34.4
Working Capital	-9,226	17,186	32,581	31,265	13,249
Book Value Per Share	161.33	641.77	717.17	769.07	416.86
Tangible Book Value	6,586	26,069	29,367	33,505	14,268
Tangible Book Value Per Share	155.76	616.21	694.16	767.18	414.73
Machinery	446.5	1,420	956.57	270.72	156.08

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 4, 2026

Data Sources Report a data error